Congestive Heart Failure

Paper Summary:

This paper, written by a registered nurse, analyzes congestive heart failure and provides a detailed discussion about treatment options. In particular, the author discusses the use of Spironolactone, and offers statistical as well as anecdotal evidence about its.

From the Paper:

"This article proposes the treatment solution of Spironolactone, a known "specialized antagonist of aldosterone" (Margo, npg)by using this drug patients can reduce their risk of mortality because it, "causes increased amounts of water and sodium to be excreted while potassium is conserved" (Margo, npg). The problem with this drug is that its effectiveness has not been adequately proven, although previous tests show that it has a positive effect on patients, not only the sample size in the article but the ethnic groups used in the experiment are greatly biased and do not reflect it as a treatment potent for all types of people. Furthermore, tests on its effectiveness compared to standard treatments did not include beta blockers which is an effect treatment already identified. This article does not adequately address the testing procedure."

More papers on Congestive Heart Failure:

• Research Paper # 131401 : "ANP and Congestive Heart Failure"
• Term Paper # 127245 : "Congestive Heart Failure"
• Term Paper # 92055 : "Congestive Heart Failure"
• Essay # 59051 : "Congestive Heart Failure"

APA Citation:

MLA Citation: